US experts identify steps to expand, improve antibody tests in COVID-19 response – Xinhua | – Xinhua

WASHINGTON, June 23 (Xinhua)– More than 300 researchers and clinicians from the U.S. federal government, industry and academic community released a report on Tuesday of their conclusions and suggestions on COVID-19 serology research studies.
The group collected for an online workshop in May to go over the function of serology screening in understanding and reacting to the COVID-19 public health crisis, and to check out techniques to address crucial clinical understanding chances and spaces in the emerging field.
They assessed efforts to much better comprehend the implications of serology test results, to produce and verify test kits, and to measure undetected cases of SARS-CoV-2 infection.
They advised that extra research is needed to identify if and to what level a positive antibody test suggests a person might be safeguarded from reinfection with SARS-CoV-2. Up until such data is available, serology tests ought to not be utilized as a stand-alone tool to make decisions about individual security associated with SARS-CoV-2 direct exposure.
Researchers are pursuing studies in humans and in animal models to better comprehend SARS-CoV-2 immunity. They kept in mind that such understanding might assist determine optimal donors of convalescent plasma that possibly could be used to help deal with those with serious COVID-19.
Serology tests for COVID-19 are designed to identify antibodies versus SARS-CoV-2, the infection that triggers COVID-19. While such tests do not identify active infection, they can indicate prior infection with SARS-CoV-2 that may have been missed due to the fact that an individual did not experience significant symptoms or gain access to testing while infected. Enditem